تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

دواعي استعمال تريباتنس 40/10/12.5 مجم 30 قرص

معلومات من نشرات دوائية ومراجع موثقة، مع مصدر كل معلومة. السعر الحالي: 126ج.م.

عن الدواء

Olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg film-coated tablets, pack of 30 (Rameda, Egypt).

دواعي الاستعمال
  • علاج ارتفاع ضغط الدمالفئة: AdultsDailyMed (U.S. National Library of Medicine)
الآثار الجانبية
  • Most common: dizziness, peripheral oedema, headache, fatigue, nasopharyngitis, muscle spasms, nausea, upper respiratory tract infection, diarrhoea, urinary tract infection, joint swelling.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
موانع الاستعمال
  • Anuria; hypersensitivity to any component or to other sulfonamide-derived drugs (hydrochlorothiazide component).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Do not co-administer aliskiren in patients with diabetes.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطات
  • Hypotension in volume- or salt-depleted patients: correct before administration.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Increased angina or myocardial infarction may occur on starting or increasing a calcium channel blocker.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Electrolyte and metabolic imbalances: hypokalaemia, hyponatraemia, hypomagnesaemia (HCTZ) or hyperkalaemia (olmesartan); may alter glucose tolerance.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Impaired renal function; exacerbation or activation of systemic lupus erythematosus; acute angle-closure glaucoma (HCTZ).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Sprue-like enteropathy has been reported with olmesartan; consider discontinuation when no other aetiology is found.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائية
  • NSAIDs (including COX-2 inhibitors)May increase risk of renal impairment and reduce antihypertensive and diuretic effect.DailyMed (U.S. National Library of Medicine)
  • Dual RAS blockade (ACE inhibitors, ARBs, aliskiren)Increased risk of renal impairment, hypotension and hyperkalaemia; aliskiren contraindicated in diabetes.DailyMed (U.S. National Library of Medicine)
  • LithiumIncreases in serum lithium concentrations and lithium toxicity.DailyMed (U.S. National Library of Medicine)
  • ColesevelamGive olmesartan at least 4 hours before colesevelam.DailyMed (U.S. National Library of Medicine)
  • SimvastatinLimit simvastatin to 20 mg daily with amlodipine.DailyMed (U.S. National Library of Medicine)
  • Cyclosporine, tacrolimusAmlodipine may increase their exposure.DailyMed (U.S. National Library of Medicine)
  • Strong/moderate CYP3A inhibitorsIncreased amlodipine exposure.DailyMed (U.S. National Library of Medicine)
  • Antidiabetic drugs; cholestyramine/colestipolAntidiabetic dose adjustment may be needed; bile acid resins reduce thiazide absorption.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعة
  • BOXED WARNING - fetal toxicity: drugs acting directly on the renin-angiotensin system can cause injury and death to the developing fetus; discontinue as soon as pregnancy is detected.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Breastfeeding is not recommended.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
المتابعة أثناء العلاج
  • Monitor renal function and potassium in susceptible patients; observe for fluid or electrolyte imbalance.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

المصادر